Dr. Dominique Tierny
Dominique Tierny (DVM, founder) has more than 15 years of experience in clinical oncology. She founded the first French referral center in veterinary oncology. She acts as Chairman of the Company and as Medical Scientific Advisor in veterinary oncology.
Matthieu Dubruque has 10 years of experience in Business Development and Operation Management in the biopharmaceutical industry. He is a graduate of the ISA-Lille Engineering School, Wageningen University (Msc Biotechnologies) and hold a MBA in part-time in 2010-2011.
Stéphane Postic, business graduate from the EM Lyon University, has held several financial management positions in large international distribution companies such as Pinault-Printemps-Redoute and Carrefour. He has been responsible for financial reporting and management of several business units in France and in the UK and has gained solid experience in profit centre management. In charge of the IPO of Genfit in 2006, he gained a strong experience in biotech financing. Working part-time as CFO of Da Volterra & OCR, Stephane brings both his high technical expertise in finance and corporate administration and his strategic advice.
Dr. François Serres
François Serres (DVM, co-founder) is specialized in internal medicine and cardiology. He is responsible for the identification and characterization of new relevant animal models and act as a scientific advisor in cardiology.
With a Master’s Degree in Control and Quality Assurance of Drugs from the Châtenay-Malabry Faculty of Pharmacy (Paris XI), Virginie Coste is a specialist in the quality and regulatory procedures in the field of health product development (Drugs, Food Supplements, Medical Devices...). She has more than 13 years of experience in the operational management of clinical trials (in Biotech and CRO companies). She is Chief Operations Officer and responsible of Regulatory Affairs at OCR, and guarantees the quality of the projects and services offered to our clients.
Dr. Quentin Pascal
Quentin Pascal, DVM, is specialized in anatomic pathology. He is graduated from Nantes & Alfort Veterinary Schools. He is now in charge of the laboratory at OCR.
Olivia Gaumétou is graduated from the Engineering school Lasalle Beauvais and holds a Master degree in Clinical Nutrition. She has more than 5 years’ experience in clinical trials both in the pharmaceutical field and in food supplements. She is responsible of clinical trials set up, conducting and monitoring at OCR.
Séverine Wadoux (Bsc) is specialized in veterinary nursing. She is in charge of the monitoring of clinical trials at OCR.
Dr. Sandy Courapied
Sandy Courapied (PhD) is specialized in clinical research in Oncology. She is in charge of the monitoring of clinical trials at OCR.
Emmanuel Bouchaert (Bsc) is specialized in in vitro & in vivo experiments. He is responsible of in vitro & in vivo experiments at OCR.
Nathalie Moulin has a strong experience in administrative coordination and she is pursuing this mission at OCR.
Tiffany Cheval has a degree in Biological Engineering and is specialized in quality management. She has three years of experience in Human Pathological Anatomy and Cytology. She is in charge of the Laboratory’s technical platform and responsible for Biobank at OCR.
Audrey Willekens has a significant administrative, management and accounting experience in Biotech and CRO companies. She is in charge of administrative management of human resources and accounting at OCR.
Floriane Borey, communication student in ISTC, is in charge of the community management of the company.
Bernadette Rogez (DVM) joined OCR and the University of Lille as a PhD student on canine mammary carcinoma.
Zacharie Segaoula is graduated from the faculty of pharmacy of the University of Rennes and holds a Master’s degree in pharmacology. PhD student at OCR in partnership with the University of Lille and the IRCL, he works on canine melanoma.
Dr. Juliette Hordeaux
Juliette Hordeaux (DVM, PhD, Dip. ECVP) is specialized in anatomic pathology & she held a PhD in neurology. She is currently consultant for R&D activities at OCR.